Duration of maternally derived antibody against measles: A seroepidemiological study of infants aged under 8 months in Qinghai, China

Vaccine

Volumn 30, Issue 4, 2012, Pages 752-757

  Zhang, Xinwei ^a   Shirayama, Yoshihisa ^a   Zhang, Yongji ^b   Ba, Wensheng ^b   Ikeda, Nayu ^a   Mori, Rintaro ^a   Shibuya, Kenji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Antibody; Infants; Maternally derived; Measles; Seroepidemiology

Indexed keywords

MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

AGE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE POLICY; HUMAN; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MOTHER; PRIORITY JOURNAL; PUBLIC HEALTH; SEROEPIDEMIOLOGY;

ADULT; ANTIBODIES, VIRAL; CHINA; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MEASLES; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS;

EID: 84855354740     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.078     Document Type: Article

References (36)

1. Mgone J.M., Mgone C.S., Duke T., Frank D., Yeka W. Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. PNG Med J 2000, 43(March-June (1-2)):91-97.
2. Clements C.J., Cutts F.T. The epidemiology of measles: thirty years of vaccination. Curr Top Microbiol Immunol 1995, 191:13-33.
3. Wolfson L.J., Strebel P.M., Gacic-Dobo M., Hoekstra E.J., McFarland J.W., Hersh B.S. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 2007, 369(January (9557)):191-200.
4. WHO Measles mortality reduction and regional elimination. Strategic plan 2001-2005 2000, World Health Organization.
5. Martins C.L., Garly M.L., Bale C., Rodrigues A., Ravn H., Whittle H.C., et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 2008, 337:a661.
6. WHO Expanded programme on immunization 1986.
7. WHO Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Collaborative study by the Ministry of Health of Kenya and the World Health Organization. Bull World Health Organ 1977, 55(1):21-31.
8. Hartter H.K., Oyedele O.I., Dietz K., Kreis S., Hoffman J.P., Muller C.P. Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J 2000, 19(July (7)):635-641.
9. Markowitz L.E., Albrecht P., Rhodes P., Demonteverde R., Swint E., Maes E.F., et al. Changing levels of measles antibody titres in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics 1996, 97(January (1)):53-58.
10. Zanetta R.A., Amaku M., Azevedo R.S., Zanetta D.M., Burattini M.N., Massad E. Optimal age for vaccination against measles in the State of Sao Paulo, Brazil, taking into account the mother's serostatus. Vaccine 2001, 20(October (1-2)):226-234.
11. Maldonado Y.A., Lawrence E.C., DeHovitz R., Hartzell H., Albrecht P. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 1995, 96(September (3 Pt 1)):447-450.
12. WHO Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(35):349-360.
13. Wenyuan Z. Expanded program on immunization 2001, Shanghai Publishing House of Scientific and Technological Literature, Shanghai.
14. Lixia W., Guang Z., Lee L.A., Zhiwei Y., Jingjin Y., Jun Z., et al. Progress in accelerated measles control in the People's Republic of China, 1991-2000. J Infect Dis 2003, 187(May (Suppl. 1)):S252-S257.
15. Dai-hong Z., Wei-jun W., Qing W. Analysis of measles epidemiological surveillance in Chongqing from 2001 to 2005. Mod Prev Med 2007, 14:2722-2727.
16. Diao L.Q., Kang K., Zhang Y.Y., Ye Y. Study on the epidemiological characteristics of measles in Henan province during 2004-2006. Zhonghua Liu Xing Bing Xue Za Zhi 2007, 28(August (8)):761-764.
17. Ping L., Xi-zhen L., Yi L. Analysis on measles epidemiology and controling measures in Shaanxi province. Chin J Public Health 2008, 24(1):48-49.
18. Li L., Yu W.Z., Shui T.J., Ma C., Wen N., Liang X.F. Analysis on epidemiological characteristics of age distribution of measles in China during 2003-2006. Chin J Vaccines Immun 2007, 13(2):101-105.
19. Wu T. Fighting against measles: the history and present status in China. Chin J Epidemiol 2000, 21(2):143-146.
20. Yang Z.H., Wang X.H., Zhu Q.R. Clinical epidemiological characteristics of children with measles in Shanghai from January to June in 2005. Chin J Infect Dis 2007, 25(1):25-28.
21. Youwang Y., Yong X., Yong H., Bo Wang, Shicheng Li, Aiguo Xu. Observation on protective titre of ELISA IgG antibody to measles virus. China Pub Health 1990, 2:3-4. [in Chinese].
22. Youwang Y., Ping W., Feng C. Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6-15 months. Vaccine 2001, 19(February (15-16)):1998-2005.
23. Xiaohua Z., Xiaolin Z., Bin L. Analysis of antibody level to measles in mothers and their infants. Chin J Health Lab Technol 2008, 18(6):1143-1144.
24. Xu G.Z., Ma R., Xu H.J., Ma Y.H., Dong H.J., Li Y., et al. Levels of transition on maternal transferred measles antibody in infants in 3 cities in China. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29(November (11)):1074-1077.
25. Rui M., Guozhang X., Hongjun D. Maternal-infant pairs comparative study on the change of maternal transferred measles antibody level in infants. Chin J Public Health 2008, 24(6):747-748.
26. de Francisco A., Hall A.J., Unicomb L., Chakraborty J., Yunus M., Sack R.B. Maternal measles antibody decay in rural Bangladeshi infants-implications for vaccination schedules. Vaccine 1998, 16(April (6)):564-568.
27. Janaszek W., Slusarczyk J. Immunity against measles in populations of women and infants in Poland. Vaccine 2003, 21(June (21-22)):2948-2953.
28. Kumar M.L., Johnson C.E., Chui L.W., Whitwell J.K., Staehle B., Nalin D. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers. Vaccine 1998, 16(December (20)):2047-2051.
29. Bromberg K., Shah B., Clark-Golden M., Light H., Marcellino L., Rivera M., et al. Maternal immunity to measles and infant immunity at less than twelve months of age relative to maternal place of birth. J Pediatr 1994, 125(October (4)):579-581.
30. Brugha R., Ramsay M., Forsey T., Brown D. A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect 1996, 117(December (3)):519-524.
31. Dagan R., Slater P.E., Duvdevani P., Golubev N., Mendelson E. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Pediatr Infect Dis J 1995, 14(November (11)):965-969.
32. De Serres G., Joly J.R., Fauvel M., Meyer F., Masse B., Boulianne N. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine 1997, 15(April-May (6-7)):620-623.
33. Pabst H.F., Spady D.W., Marusyk R.G., Carson M.M., Chui L.W., Joffres M.R., et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J 1992, 11(July (7)):525-529.
34. Linder N., Tallen-Gozani E., German B., Duvdevani P., Ferber A., Sirota L. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status. Vaccine 2004, 22(March (11-12)):1509-1514.
35. Mao N.Y., Jiang X.H., Wu L.P., Nan L.J., Xu W.B. Comparative study on application of quantitative ELISA for detection of measles antibody. Chin J Vaccines Immun 2005, 11(3):187-189.
36. Gagneur A., Pinquier D., Aubert M., Balu L., Brissaud O., De Pontual L., et al. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006. Clin Vaccine Immunol 2008, 15(December (12)):1845-1850.